US Archives - Page 75 of 100 - European Medical Journal

Rwanda Nears End of Marburg Outbreak

Rwanda has begun the 42-day countdown to officially declare an end to the Marburg virus outbreak, having discharged its last patient on November 8, 2024.

How Does Asthma Alter Children’s Memory Development?

Children with asthma, particularly those with an early onset, may experience slower memory development and face challenges in cognitive functions.

New Algorithm Enhances Precision in Long COVID Cohorts

Researchers have developed a precision phenotyping algorithm that significantly advances the identification of long COVID, or post-acute sequelae of COVID-19 (PASC), in patient records.

Newborn Genome Screening Shows 99.6% Success Rate

In a landmark study conducted across six New York City hospitals, researchers have found that genomic sequencing can significantly enhance newborn screening by detecting additional actionable conditions beyond the current standard newborn screening (NBS) program.

New Genetic Insight on Leukemia Treatment Resistance

A genetic variant, the BIM deletion polymorphism (BDP), has been identified by researchers to significantly enhance leukemia stem and progenitor cells’ survival, making them resistant to common targeted therapies.

Once-Weekly Semaglutide: Relief for Knee Pain?

In a groundbreaking study, once-weekly semaglutide injections were shown to significantly reduce both knee osteoarthritis pain and body weight in adults with obesity, offering promising new relief for patients with limited treatment options.

Unequal Insurance Coverage Worsens Cancer Outcomes

A powerful link between health insurance status and racial and ethnic disparities in advanced cancer diagnoses has been identified in a recently published study.

Emerging Evidence for Laser Hair Removal in Treating Hidradenitis Suppurativa

New evidence highlights the potential of laser hair removal and intense pulsed light (IPL) therapy in reducing lesion count and flare-ups for patients with hidradenitis suppurativa (HS).

FDA Proposes OTC Ban for Oral Phenylephrine

The FDA has announced it is proposing removing oral phenylephrine from the list of over-the-counter (OTC) nasal decongestant ingredients due to extensive evidence questioning its effectiveness.

Interview: Gail J Demmler–Harrison

As an undergraduate student at the University of Texas in Austin, USA studying pre-med and microbiology, I gravitated towards the virology…